Sector--
Established Date05/01/1987
Listing Date02/09/2005
ExchangeNASDAQ Stock Exchange
Full-time Employees60
Fiscal Year Ends30/06
Security TypeDepository Receipts (Ordinary Shares)
Office addressLevel 5, 126-130 Phillip Street, SYDNEY, NSW, AUSTRALIA, 2000
BusinessGenetic risk test
IntroductionGenetic Technologies Limited was incorporated under the laws of Western Australia on 5 January 1987 as Concord Mining N.L. The company is a molecular diagnostic company that provides predictive testing and assessment tools to help physicians proactively manage people's health. The company's traditional product, BREVAGenplus, is a clinically proven non-hereditary breast cancer risk assessment test, the first of its kind. BREVAGenplus improves the predictive power of the first-generation BREVAGen test, designed to facilitate more informed decisions about breast cancer screening and preventive treatment plans.
